141 related articles for article (PubMed ID: 2957596)
21. The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects.
Kathagen-Buhmann A; Maire CL; Weller J; Schulte A; Matschke J; Holz M; Ligon KL; Glatzel M; Westphal M; Lamszus K
Neuro Oncol; 2018 Nov; 20(12):1594-1605. PubMed ID: 30053149
[TBL] [Abstract][Full Text] [Related]
22. Biochemical mechanisms of tumor invasion and metastases.
Liotta LA; Wewer U; Rao NC; Schiffmann E; Stracke M; Guirguis R; Thorgeirsson U; Muschel R; Sobel M
Prog Clin Biol Res; 1988; 256():3-16. PubMed ID: 2835781
[TBL] [Abstract][Full Text] [Related]
23. A tumor derived motility factor that stimulates cell migration on extracellular matrix.
Klominek J; Robért KH; Sundqvist KG
Anticancer Res; 1998; 18(3A):1601-12. PubMed ID: 9673377
[TBL] [Abstract][Full Text] [Related]
24. Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2).
Sugiura T; Berditchevski F
J Cell Biol; 1999 Sep; 146(6):1375-89. PubMed ID: 10491398
[TBL] [Abstract][Full Text] [Related]
25. Pseudopodial and β-arrestin-interacting proteomes from migrating breast cancer cells upon PAR2 activation.
Parisis N; Metodieva G; Metodiev MV
J Proteomics; 2013 Mar; 80():91-106. PubMed ID: 23313222
[TBL] [Abstract][Full Text] [Related]
26. Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events.
Timár J; Tóth S; Tóvári J; Paku S; Raz A
Clin Exp Metastasis; 1999; 17(10):809-16. PubMed ID: 11089878
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effects of autocrine motility factor and methyl jasmonate on human breast cancer cells.
Jeoung NH; Jo AL; Park HS
Biochem Biophys Res Commun; 2021 Jun; 558():22-28. PubMed ID: 33894674
[TBL] [Abstract][Full Text] [Related]
28. α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma.
Ito M; Hagiyama M; Mimae T; Inoue T; Kato T; Yoneshige A; Nakanishi J; Kondo T; Okada M; Ito A
Breast Cancer Res Treat; 2014 Feb; 144(1):59-69. PubMed ID: 24496929
[TBL] [Abstract][Full Text] [Related]
29. Purification and characterization of beta-actin-rich tumor cell pseudopodia: role of glycolysis.
Nguyen TN; Wang HJ; Zalzal S; Nanci A; Nabi IR
Exp Cell Res; 2000 Jul; 258(1):171-83. PubMed ID: 10912799
[TBL] [Abstract][Full Text] [Related]
30. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Watanabe H; Takehana K; Date M; Shinozaki T; Raz A
Cancer Res; 1996 Jul; 56(13):2960-3. PubMed ID: 8674049
[TBL] [Abstract][Full Text] [Related]
31. Detection of autocrine motility factor in urine as a marker of bladder cancer.
Guirguis R; Schiffmann E; Liu B; Birkbeck D; Engel J; Liotta L
J Natl Cancer Inst; 1988 Oct; 80(15):1203-11. PubMed ID: 3138430
[TBL] [Abstract][Full Text] [Related]
32. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
[TBL] [Abstract][Full Text] [Related]
33. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization.
Akiyama SK; Yamada SS; Chen WT; Yamada KM
J Cell Biol; 1989 Aug; 109(2):863-75. PubMed ID: 2527241
[TBL] [Abstract][Full Text] [Related]
34. Heregulin regulation of autocrine motility factor expression in human tumor cells.
Talukder AH; Adam L; Raz A; Kumar R
Cancer Res; 2000 Jan; 60(2):474-80. PubMed ID: 10667603
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Ueda Y; Wang S; Dumont N; Yi JY; Koh Y; Arteaga CL
J Biol Chem; 2004 Jun; 279(23):24505-13. PubMed ID: 15044465
[TBL] [Abstract][Full Text] [Related]
36. Progress in protrusion: the tell-tale scar.
Svitkina TM; Borisy GG
Trends Biochem Sci; 1999 Nov; 24(11):432-6. PubMed ID: 10542409
[TBL] [Abstract][Full Text] [Related]
37. Recruitment of the Arp2/3 complex to vinculin: coupling membrane protrusion to matrix adhesion.
DeMali KA; Barlow CA; Burridge K
J Cell Biol; 2002 Dec; 159(5):881-91. PubMed ID: 12473693
[TBL] [Abstract][Full Text] [Related]
38. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor.
Watanabe H; Carmi P; Hogan V; Raz T; Silletti S; Nabi IR; Raz A
J Biol Chem; 1991 Jul; 266(20):13442-8. PubMed ID: 1649192
[TBL] [Abstract][Full Text] [Related]
39. Regulation of cell motility via high and low affinity autocrine motility factor (AMF) receptor in human oral squamous carcinoma cells.
Niinaka Y; Haga A; Negishi A; Yoshimasu H; Raz A; Amagasa T
Oral Oncol; 2002 Jan; 38(1):49-55. PubMed ID: 11755821
[TBL] [Abstract][Full Text] [Related]
40. FiloQuant reveals increased filopodia density during breast cancer progression.
Jacquemet G; Paatero I; Carisey AF; Padzik A; Orange JS; Hamidi H; Ivaska J
J Cell Biol; 2017 Oct; 216(10):3387-3403. PubMed ID: 28765364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
